William Bertrand

COO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

ADAPY

Current role

COO

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2023	Adaptimmune Therapeutics PLC (ADAPY)	Chief Operating Officer	$468,179	—	—	$507,762	$200,147	$39,012	$1,215,100
2022	Adaptimmune Therapeutics PLC (ADAPY)	Chief Operating Officer	$468,179	—	—	$814,474	$63,204	$42,415	$1,388,271
2021	Adaptimmune Therapeutics PLC (ADAPY)	Chief Operating Officer	$456,760	—	—	$1,069,101	$195,265	$35,062	$1,756,188
2020	Adaptimmune Therapeutics PLC (ADAPY)	Chief Operating Officer	$443,456	—	—	$857,661	$219,511	$30,485	$1,551,113
2019	Adaptimmune Therapeutics PLC (ADAPY)	Chief Operating Officer	$432,640	—	—	$766,900	$136,282	$35,358	$1,371,180

No earnings-call appearances or filed executive changes recorded yet.